Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20
BW Businessworld

Meril Receives Nod From ICMR For Its Indigenous COVID-19 Self-Test Kit

The test kit is equipped with testing materials including a test device, one sterile nasal swab and a pre-filled buffer tube with a cap and is priced at Rs 250 as an affordable single-pack

Photo Credit :

1501136162_oEfseY_data-in-health.jpg

mckinsey.com/industries/healthcare

Medtech firm Meril on Thursday said it has received approval from the Indian Council of Medical Research (ICMR) for its self-use rapid antigen test kit for COVID-19.

The company's indigenous home-use rapid antigen test kits 'CoviFind' will expand access to COVID-19 testing, while also helping the nation meet the demand for increased and frequent screening to curb the spread of the pandemic, Meril said in a statement.

The test delivers results swiftly, providing accurate results in 15 minutes, it added.

'By making reliable rapid antigen testing available to all through a convenient format, Meril's CoviFind test will facilitate early detection, isolation, treatment and contact tracing,' Meril Senior Vice-President (Corporate Strategy) Sanjeev Bhatt said.

The test kit is equipped with testing materials including a test device, one sterile nasal swab and a pre-filled buffer tube with a cap and is priced at Rs 250 as an affordable single-pack, the company said.

The test kits will be available in two weeks at retail pharmacies, e-pharmacies and through e-commerce platforms including Amazon and Flipkart, it added.

Meril said it has also supplied a large number of tests across its COVID-19 diagnostics offerings across India, which include a multiplex RT-PCR test, Kavach antibody tests in partnership with ICMR. 

(PTI)